Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Clinical trial NCT02631551 · COMPLETED
Trial details
- NCT number
- NCT02631551
- Sponsor
- Glenmark Specialty S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-07-01
- Enrollment
- 1180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.